🇺🇸 Invirase in United States

672 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Pain — 89 reports (13.24%)
  2. Anxiety — 88 reports (13.1%)
  3. Emotional Distress — 87 reports (12.95%)
  4. Anhedonia — 76 reports (11.31%)
  5. Drug Exposure During Pregnancy — 66 reports (9.82%)
  6. Renal Failure — 58 reports (8.63%)
  7. Depression — 55 reports (8.18%)
  8. Anaemia — 54 reports (8.04%)
  9. Chronic Kidney Disease — 50 reports (7.44%)
  10. Pyrexia — 49 reports (7.29%)

Source database →

Invirase in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in United States

Frequently asked questions

Is Invirase approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Invirase in United States?

Saint Michael's Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.